Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
December 9, 2019

Bristol-Myers Squibb’s Liso-Cel meets key endpoints in blood cancer trial

Bristol-Myers Squibb announced that its blood cancer treatment lisocabtagene maraleucel (liso-cel) has achieved its primary and secondary endpoints in TRANSCEND NHL 001 study.

Continue
Image: Bristol-Myers Squibb’s blood cancer treatment Liso-Cel has achieved primary and secondary endpoints in TRANSCEND NHL 001 study. Photo: courtesy of Rept0n1x.
December 9, 2019

XBiotech to sell anti- IL-1⍺ antibody bermekimab to Janssen in $1.3bn deal

XBiotech to sell bermekimab to Janssen. Photo: courtesy of Tumisu from Pixabay.
December 6, 2019

ViiV Healthcare seeks FDA approval for fostemsavir to treat HIV-1 infection

Image: ViiV Healthcare is seeking FDA approval for fostemsavir to treat HIV-1 infection. Photo: courtesy of Darwin Laganzon from Pixabay.

Contracts

November 22, 2019

ViiV Healthcare, NIH collaborate on investigational bNAb for HIV treatment

Image: ViiV Healthcare to develop investigational bNAbs. Photo: Courtesy of GlaxoSmithKline plc.

WuXi Biologics signed letter of intent for long-term vaccine manufacturing contract

TaiwanJ Pharmaceuticals out-licenses liver drug candidate in Asia

GeoVax, Leidos expand collaboration to malaria vaccines

Deals

Deals December 3, 2019

STADA to acquire Biopharma’s prescription and consumer health business

Pharmaceutical Business Review

Astellas Pharma to buy Audentes Therapeutics for $3bn

Asahi Kasei to acquire Veloxis Pharmaceuticals for $1.3bn

Novartis to buy The Medicines Company for $9.7bn

Popular

  1. Gilead, Renown Institute for Health Innovation announce collaboration to advance understanding of NASH
  2. Celsius Therapeutics signs collaboration agreement with Janssen to identify response biomarkers for ulcerative colitis
  3. Ipsen, Servier announce initial phase 1/2 data of liposomal irinotecan in metastatic pancreatic cancer
  4. VALBIOTIS announces positive results from phase IIA trial of VALEDIA in prediabetics
  5. GSK begins phase 3 trial for otilimab in patients with rheumatoid arthritis

PRESS RELEASES

7PSolutions Joins Forces with Eye-Seal’s Smart Internal Container Breach Detection Technology
7PSolutions Joins Forces with Eye-Seal’s Smart Internal Container Breach Detection Technology
30 Years One-Stop-Shop for Protein Purification and Analysis
30 Years One-Stop-Shop for Protein Purification and Analysis
Optibrium Collaborates with Enamine and BioSolveIT to Add REAL Space Search Tool to StarDrop
Optibrium Collaborates with Enamine and BioSolveIT to Add REAL Space Search Tool to StarDrop
Black Friday Special Training Offers from NSF
Black Friday Special Training Offers from NSF
Cyclica Collaborates With Enamine to Use REAL Technology in Its Ligand Design Platform for AI-augmented Drug Design
Cyclica Collaborates With Enamine to Use REAL Technology in Its Ligand Design Platform for AI-augmented Drug Design

Suppliers

Whitepapers

Oxetanes
Oxetanes
SF5-Containing Building Blocks
SF5-Containing Building Blocks
Wondering how to improve your material release process?
Wondering how to improve your material release process?